Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/05/2022* -- Results Q4 2022 -- 1.45 --
08/05/2022* 16:30 EST Earnings Call Q4 2022 -- -- --
04/28/2022 -- Results Q3 2022 1.32 1.44 -8.13%
04/28/2022 16:30 EST Earnings Call Q3 2022 -- -- --
01/27/2022 -- Results Q2 2022 1.47 1.52 -3.50%
01/27/2022 16:30 EST Earnings Call Q2 2022 -- -- --
10/28/2021 -- Results Q1 2022 1.51 1.35 11.69%
10/28/2021 16:30 EST Earnings Call Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/05/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 04/28/2022
Beat/Miss Upgrade
Return Since -6.84%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
URL https://www.resmed.com
Investor Relations URL https://investors.resmed.com/investor-relations/default.aspx
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Growth
Next Earnings Release Aug. 05, 2022 (est.)
Last Earnings Release Apr. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 11, 2022

Dividends

Dividend Per Share (TTM) 1.65
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.6388
Yield to Sector 0.4405
Yield to Industry 1.091
Last Dividend Amt. 0.42
Dividend Frequency Quarterly
Last Ex-Dividend Date May. 11, 2022
Yield (TTM) 0.85%
Forward Yield 0.85%
Payout Ratio 30.87%
Cash Payout Ratio 70.02%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-2.30%
18.02%
39.07%
36.38%
37.86%
38.34%
23.41%
-23.51%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-16.13%
-6.46%
9.88%
60.13%
-0.98%
1.50%
27.61%
32.40%
11.46%
39.17%
17.30%
14.61%
42.56%
27.96%
-20.50%
18.16%
-6.10%
59.29%
-12.42%
222.6%
-41.84%
-24.64%
19.84%
-50.83%
-25.32%
--
--
--
--
28.09%
434.1%
143.1%
-45.81%
As of May 23, 2022.

Profile

Edit
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
URL https://www.resmed.com
Investor Relations URL https://investors.resmed.com/investor-relations/default.aspx
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Growth
Next Earnings Release Aug. 05, 2022 (est.)
Last Earnings Release Apr. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date May. 11, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
TMFM 9.264M USD 4.42%
FSMEX 363.76M USD 4.03%
WCMRX 1.027B USD 3.58%
IHI 188.98M USD 2.71%
INGFX 241.35M USD 2.36%
BMEZ 47.72M USD 1.89%
FIGSX 268.22M USD 1.84%
FSPHX 116.40M USD 1.25%
VMGIX 197.40M USD 0.99%
VOT 197.40M USD 0.99%
IWP 99.17M USD 0.88%
IMCG 8.724M USD 0.86%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter RMD Tweets